Lifestance Health Group, Inc. (LFST)

LifeStance Health Group's stock has been influenced by its Q3 and Q2 2025 results. In Q3, revenue was $364 million, a 16% year-over-year increase, and adjusted EBITDA reached $40 million, a 31% year-over-year increase. In Q2, EPS was -$0.01, and the company generated a record free cash flow of $57 million, revising its full-year adjusted EBITDA guidance upwards. The stock's 52-week high was $8.29, and its low was $3.75. Analysts have given a consensus rating of "Buy" with an average price target of $9.04. Insider selling was noted, but institutional investors have been accumulating shares.

The demand for mental health services offered by LifeStance Health Group is generally strong and growing, without significant seasonality. Factors driving demand include the mental health crisis, increased awareness, and the rise of telemental health. Mental health-related telehealth visits are consistently high, and the recurring nature of treatment for chronic conditions contributes to stable demand.

LifeStance Health Group, Inc. operates in the Healthcare Facilities & Services sector, focusing on outpatient mental health care for children, adolescents, and adults. They offer psychiatric evaluations, psychological testing, and various therapies, addressing conditions like anxiety and depression. The company employs approximately 8,000 mental health professionals and uses an evidence-based approach, providing both virtual and in-person visits.

LifeStance Health Group, Inc. operates in 33 states with more than 550 centers across the United States.

LifeStance Health Group has established itself as a reliable provider in the mental health market. A survey indicated that most Americans do not consider social media a substitute for clinical treatment, reinforcing the value of professional care. The company's hybrid care model is seen as a critical response to public health needs, designed to improve patient outcomes and reduce healthcare costs.

LifeStance Health Group, Inc.'s ownership is predominantly institutional, with 91.0% of the company's outstanding stock held by institutional owners and shareholders. Major institutional owners include TPG GP A, LLC, FMR LLC, Summit Partners L.P., BlackRock, Inc., and Vanguard Group Inc. Individual investors account for about 9.0% of the ownership.